Return to: Medical School : Academic Health Center : myAHC : U of M Home

Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
IPTR masthead graphic
Whats Inside
Contact Us

About Us

Registry Staff

Annual Reports

IPTR Database

IPTR Links

Slide Library

 

IPTR Home

Home > Annual Reports > 2000 Annual Report > Outcome Effects: Recipient Age, Diabetes Type, Venous Vascular Management for USA Cases

Printer-friendly version   Mail this page to a friend

Outcome Effects: Recipient Age, Diabetes Type, Venous Vascular Management for USA Cases


Effect of Recipient Age on Outcome by Era

Pancreas transplant outcome has improved over time in recipients >45 years of age and the proportion of these recipients has increased from 4% in 1988 to 26% in 2000.

For SPK recipients, patient survival improved from 76% in the 1987-90 era to 93% in the 1998-2000 era and pancreas graft survival improved from 62% in the 1987-90 era to 78% in the 1998-2000 era.

In the solitary groups, there were few recipients >45 in the early eras. However, in the PAK group, patient survival change, while not statistically significant, went from 78% in the 1987-90 era to 91% in both the 1996-97 and 1998-2000 eras. PAK pancreas graft survival did significantly improve from 44% in the 1987-90 era to 73% in the 1998-2000 era. For PTAs, patient survival has been 100% for the last three eras and has always been at least always 80%. PTA graft survival has dramatically improved from 54% in the 1991-93 era to 87% in the 1998-2000 era.

Effect of Diabetes Type on SPK Outcome for 1996-2000 cases

Of 1996-2000 cadaver SPK recipients (n=3494), only 4% were classified as type 2 (type 1 n=3323, type 2 n=157). Age ranges were 16-69 (mean 38+7 years) for type 1 and 31-59 (mean 44+7 years) for type 2, (P=0.0001). Neither patient survival rates nor pancreas graft survival rates had statistically significant differences between type 1 and type 2 cases. For type 1, patient survival at 1 year was 95% and pancreas graft survival was 73%; for type 2, rates were 91% and 71% respectively.

Effect of Venous Vascular Management on SPK Outcome for 1996-2000 cases

Over half the SPK transplants (55%) were done using enteric drainage (ED). Of the cases with complete records for analysis of the effect on outcome of systemic versus portal venous vascular management (n=1920), about 21% (n=411) used portal versus systemic (n=1509). Pancreas graft survival rates were no different for portal versus systemic ED SPK transplants: 83% at 1 year.

Previous Page / Next Page / Index Page


Feedback | Notice of Privacy Practices

 
The University of Minnesota is an equal opportunity educator and employer.